These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 35328471)

  • 21. Biopsychological correlates of repetitive and restricted behaviors in autism spectrum disorders.
    Comparan-Meza M; Vargas de la Cruz I; Jauregui-Huerta F; Gonzalez-Castañeda RE; Gonzalez-Perez O; Galvez-Contreras AY
    Brain Behav; 2021 Oct; 11(10):e2341. PubMed ID: 34472728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Dopamine Hypothesis of Autism Spectrum Disorder.
    Pavăl D
    Dev Neurosci; 2017; 39(5):355-360. PubMed ID: 28750400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune dysfunction and neuroinflammation in autism spectrum disorder.
    Bjorklund G; Saad K; Chirumbolo S; Kern JK; Geier DA; Geier MR; Urbina MA
    Acta Neurobiol Exp (Wars); 2016; 76(4):257-268. PubMed ID: 28094817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated Polygenic Burden for Autism Spectrum Disorder Is Associated With the Broad Autism Phenotype in Mothers of Individuals With Autism Spectrum Disorder.
    Nayar K; Sealock JM; Maltman N; Bush L; Cook EH; Davis LK; Losh M
    Biol Psychiatry; 2021 Mar; 89(5):476-485. PubMed ID: 33229037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical, Genetic and Clinical Diagnostic Approaches to Autism-Associated Inherited Metabolic Disorders.
    Senarathne UD; Indika NR; Jezela-Stanek A; Ciara E; Frye RE; Chen C; Stepien KM
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder.
    Masi A; Glozier N; Dale R; Guastella AJ
    Neurosci Bull; 2017 Apr; 33(2):194-204. PubMed ID: 28238116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid and serum protein markers in autism: A co-twin study.
    Smedler E; Kleppe J; Neufeld J; Lundin K; Bölte S; Landén M
    J Neurochem; 2021 Aug; 158(3):798-806. PubMed ID: 33675537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal Antibody and ASD: Clinical Data and Animal Models.
    Gata-Garcia A; Diamond B
    Front Immunol; 2019; 10():1129. PubMed ID: 31191521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential role for immune-related genes in autism spectrum disorders: Evidence from genome-wide association meta-analysis of autistic traits.
    Arenella M; Cadby G; De Witte W; Jones RM; Whitehouse AJ; Moses EK; Fornito A; Bellgrove MA; Hawi Z; Johnson B; Tiego J; Buitelaar JK; Kiemeney LA; Poelmans G; Bralten J
    Autism; 2022 Feb; 26(2):361-372. PubMed ID: 34344231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary Phytochemicals as Neurotherapeutics for Autism Spectrum Disorder: Plausible Mechanism and Evidence.
    Bhandari R; Paliwal JK; Kuhad A
    Adv Neurobiol; 2020; 24():615-646. PubMed ID: 32006377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story.
    Carbone E; Manduca A; Cacchione C; Vicari S; Trezza V
    Neurosci Biobehav Rev; 2021 Feb; 121():128-143. PubMed ID: 33358985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling Autism-Related Disorders in Mice with Maternal Immune Activation (MIA).
    Lammert CR; Lukens JR
    Methods Mol Biol; 2019; 1960():227-236. PubMed ID: 30798536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Maternal Immune Activation in the Pathogenesis of Autism: A Review of the Evidence, Proposed Mechanisms and Implications for Treatment.
    Zawadzka A; Cieślik M; Adamczyk A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genetics of autism.
    Muhle R; Trentacoste SV; Rapin I
    Pediatrics; 2004 May; 113(5):e472-86. PubMed ID: 15121991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of immune dysfunction in the pathophysiology of autism.
    Onore C; Careaga M; Ashwood P
    Brain Behav Immun; 2012 Mar; 26(3):383-92. PubMed ID: 21906670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autism spectrum disorder and comorbidities].
    Kostiukow A; Samborski W
    Pol Merkur Lekarski; 2020 Aug; 49(286):289-292. PubMed ID: 32827428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune dysregulation in autism spectrum disorder.
    Hsiao EY
    Int Rev Neurobiol; 2013; 113():269-302. PubMed ID: 24290389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment.
    Ebrahimi Meimand S; Rostam-Abadi Y; Rezaei N
    Expert Rev Clin Immunol; 2021 Jan; 17(1):27-35. PubMed ID: 33191807
    [No Abstract]   [Full Text] [Related]  

  • 39. Examining the autistic traits in children and adolescents diagnosed with attention-deficit hyperactivity disorder and their parents.
    Okyar E; Görker I
    BMC Psychiatry; 2020 Jun; 20(1):285. PubMed ID: 32503560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes.
    Rizk M; Saker Z; Harati H; Fares Y; Bahmad HF; Nabha S
    Mol Biol Rep; 2021 Mar; 48(3):2669-2686. PubMed ID: 33650079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.